Latin America Heart Transplantation Therapeutics Market Size & Outlook

The heart transplantation therapeutics market in Latin America is expected to reach a projected revenue of US$ 85.8 million by 2030. A compound annual growth rate of 3.5% is expected of Latin America heart transplantation therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$67.3
Forecast, 2030 (US$M)
$85.8
CAGR, 2024 - 2030
3.5%
Report Coverage
Latin America

Latin America heart transplantation therapeutics market, 2018-2030 (US$M)

Latin

Latin America heart transplantation therapeutics market highlights

  • The Latin America heart transplantation therapeutics market generated a revenue of USD 67.3 million in 2023.
  • The market is expected to grow at a CAGR of 3.5% from 2024 to 2030.
  • In terms of segment, immunosuppressants was the largest revenue generating therapeutics in 2023.
  • Immunosuppressants is the most lucrative therapeutics segment registering the fastest growth during the forecast period.


Latin America data book summary

Market revenue in 2023USD 67.3 million
Market revenue in 2030USD 85.8 million
Growth rate3.5% (CAGR from 2023 to 2030)
Largest segmentImmunosuppressants
Fastest growing segmentImmunosuppressants
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunosuppressants
Key market players worldwideBristol-Myers Squibb Co, Celgene, Eisai Co Ltd, Phaxiam, Roche Holding AG, Genmab A/S, GlaxoSmithKline, Novartis AG ADR, Pfizer Inc, Sanofi SA


Other key industry trends

  • In terms of revenue, Latin America region accounted for 6.2% of the global heart transplantation therapeutics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 361.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Heart Transplantation Therapeutics Market Scope

Heart transplantation therapeutics market segmentation & scope
Anti-infectives
Analgesics
Other
Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Heart Transplantation Therapeutics Market Companies

Name Profile # Employees HQ Website

Latin America heart transplantation therapeutics market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more